Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 13	$ 40
Operating expenses:
Research and development	309	601
Management contingent share plan	764
Selling, general and administrative	6,332	4,002
Total operating expenses	7,405	4,603
Loss from operations	(7,392)	(4,563)
Non-cash change in fair value of convertible debentures		(7,432)
Interest expense	(225)	(322)
Other expense	(22)	(50)
Total non-operating expense	(247)	(7,804)
Loss before income taxes	(7,639)	(12,367)
Provision for income taxes
Net loss	$ (7,639)	$ (12,367)
Class A Common Stock
Operating expenses:
Net loss per share of Class A common stock, basic and diluted (in Dollars per share)	$ (0.33)	$ (2.12)